Related Experiment Video
Updated: Aug 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Expected hemoglobin decrease following percutaneous transluminal coronary angioplasty
W Jauch1, P B Kurnik, S J Hanlon
1Department of Medicine, UMDNJ/Robert Wood Johnson Medical School at Camden, New Jersey, USA.
Insights
This study establishes expected hemoglobin changes after percutaneous transluminal coronary angioplasty (PTCA). The findings provide benchmarks for identifying unexpected blood loss in individual patients undergoing PTCA.
Area of Science:
- Cardiology
- Hematology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure.
- Monitoring hemoglobin levels is crucial for patient safety post-procedure.
Purpose of the Study:
- To determine expected hemoglobin level fluctuations during and after PTCA.
- To establish reference intervals for identifying abnormal blood loss.
Main Methods:
- Hemoglobin levels were measured in 177 patients before, immediately after, and on two subsequent mornings following PTCA.
- Confidence and prediction intervals were calculated from the collected data.
Main Results:
- Established expected hemoglobin changes in patients undergoing PTCA.
- Provided statistical intervals to assess blood loss against expected norms.
Conclusions:
- The calculated confidence and prediction intervals can aid in detecting excessive or unexpected blood loss.
- These benchmarks are valuable for evaluating new devices and antithrombotic agents used in PTCA.
Abstract:
To establish expected changes in hemoglobin during and after percutaneous transluminal coronary angioplasty (PTCA), we measured hemoglobin before, at the end of, and on the 2 mornings after PTCA in 177 consecutive patients without obvious out-of-laboratory blood loss. From these data, we calculated confidence intervals that can be used to compare group data, possibly to identify excessive blood loss with new devices or antithrombotic agents, and prediction intervals to identify unexpected blood loss in an individual patient.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care